CLINICAL_TRIALS
trial_result
· 2011-07-26
Clinical Trial Update: Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma [Phase 2]
Summary
Phase 2 clinical trial evaluating imatinib mesylate for HIV-related Kaposi's sarcoma has completed with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AIDS Malignancy Consortium | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2011-07-26